Sánchez-Huertas, A.; Camejo-Mas, O.; Garcia-Roldan, S.; Alonso-Castillo, R.; Pulido-Fraiz, L.; Higuera Ruiz de la Hermosa, A.; Portocarrero-Sánchez, L.; DÃaz-de-Terán, J.
OnabotulinumtoxinA Is an Effective Treatment for Reducing the Interictal Burden in Patients with Chronic Migraine: A Prospective Observational Study. Toxins 2025, 17, 463.
https://doi.org/10.3390/toxins17090463
AMA Style
Sánchez-Huertas A, Camejo-Mas O, Garcia-Roldan S, Alonso-Castillo R, Pulido-Fraiz L, Higuera Ruiz de la Hermosa A, Portocarrero-Sánchez L, DÃaz-de-Terán J.
OnabotulinumtoxinA Is an Effective Treatment for Reducing the Interictal Burden in Patients with Chronic Migraine: A Prospective Observational Study. Toxins. 2025; 17(9):463.
https://doi.org/10.3390/toxins17090463
Chicago/Turabian Style
Sánchez-Huertas, Alejandro, Oscar Camejo-Mas, Sebastian Garcia-Roldan, Rocio Alonso-Castillo, Lara Pulido-Fraiz, Andrea Higuera Ruiz de la Hermosa, Leonardo Portocarrero-Sánchez, and Javier DÃaz-de-Terán.
2025. "OnabotulinumtoxinA Is an Effective Treatment for Reducing the Interictal Burden in Patients with Chronic Migraine: A Prospective Observational Study" Toxins 17, no. 9: 463.
https://doi.org/10.3390/toxins17090463
APA Style
Sánchez-Huertas, A., Camejo-Mas, O., Garcia-Roldan, S., Alonso-Castillo, R., Pulido-Fraiz, L., Higuera Ruiz de la Hermosa, A., Portocarrero-Sánchez, L., & DÃaz-de-Terán, J.
(2025). OnabotulinumtoxinA Is an Effective Treatment for Reducing the Interictal Burden in Patients with Chronic Migraine: A Prospective Observational Study. Toxins, 17(9), 463.
https://doi.org/10.3390/toxins17090463
